| Product NDC: | 58177-293 |
| Proprietary Name: | metoprolol succinate |
| Non Proprietary Name: | metoprolol succinate |
| Active Ingredient(s): | 23.75 mg/1 & nbsp; metoprolol succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58177-293 |
| Labeler Name: | Ethex Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077176 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091101 |
| Package NDC: | 58177-293-12 |
| Package Description: | 5000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58177-293-12) |
| NDC Code | 58177-293-12 |
| Proprietary Name | metoprolol succinate |
| Package Description | 5000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58177-293-12) |
| Product NDC | 58177-293 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol succinate |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20091101 |
| Marketing Category Name | ANDA |
| Labeler Name | Ethex Corporation |
| Substance Name | METOPROLOL SUCCINATE |
| Strength Number | 23.75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |